I

n the moments after a spinal cord injury, a process of degradation begins throughout the body, swiftly killing motor function and a patient’s quality of life.

Vinod Labhasetwar is using nanotechnology to try to stop that process in its tracks, injecting tiny particles containing antioxidant enzymes into patients to limit the damage from their injuries and, he hopes, preserve critical movement.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.

X